Galectin Therapeutics Inc.

$2.37
+0.08 (+3.68%)

Market Capitalization:

$155.82M

Galectin Therapeutics Price Chart

Galectin Therapeutics Price Chart4:29 PM5:49 PM7:09 PM4:29 AM5:49 AM7:09 AM8:29 AM2.372.362.352.342.332.322.31

Galectin Therapeutics Volume Chart

Galectin Therapeutics Volume Chart4:29 PM5:49 PM7:09 PM4:29 AM5:49 AM7:09 AM8:29 AM1.00K857714571429286143

Galectin Therapeutics Market Segments

Premarket

+0.04(+1.59%)
Open$2.33
Close$2.37
Low$2.32
Low Change-0.01 (-0.43%)
High$2.37
High Change+0.04 (+1.59%)
Range$0.05
Volume1.4K
Dollar Volume$3.31K

After Hours Yesterday

-0.03(-1.09%)
Open$2.34
Close$2.31
Low$2.31
Low Change-0.03 (-1.28%)
High$2.34
High Change+0.00 (+0.00%)
Range$0.03
Volume1.324K
Dollar Volume$3.06K

Regular Trading Hours Yesterday

-0.18(-7.20%)
Open$2.46
Close$2.28
Low$2.26
Low Change-0.21 (-8.33%)
High$2.46
High Change+0.00 (+0.00%)
Range$0.21
Volume378.103K
Dollar Volume$863.21K

Premarket Yesterday

-0.05(-2.00%)
Open$2.50
Close$2.45
Low$2.45
Low Change-0.05 (-2.00%)
High$2.50
High Change+0.00 (+0.00%)
Range$0.05
Volume5.2K
Dollar Volume$12.74K

Galectin Therapeutics Moving Averages

5 Day Moving Average (SMA5)$2.40
10 Day Moving Average (SMA10)$2.35
20 Day Moving Average (SMA20)$2.55
50 Day Moving Average (SMA50)$2.81
100 Day Moving Average (SMA100)$3.57
200 Day Moving Average (SMA200)$3.93

Galectin Therapeutics Statistics

Average Volume (30 Days)374.86K
P/E Ratio (Current)-5.21
EPS (Current)-$0.47
Dividend Yield0.00%
Free Cash Flow
Cash Ratio2.21
Current Ratio2.42
Quick Ratio2.42
Debt to Equity-0.26
Enterprise Value$176.26M
EV to EBITDA-8.78
EV to Sales
Price to Book-1.26
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-1.59%
Return on Equity0.24%

Galectin Therapeutics Stock Splits

There has been 1 stock split for Galectin Therapeutics (GALT). The reverse stock split occured on March 23, 2012 and reduced the outstanding shares at a ratio of 6:1.

DateTypeRatio
Mar 23, 2012Reverse6:1

Galectin Therapeutics Dividends

There have been no dividends for Galectin Therapeutics (GALT).